Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

49.52
-1.2300-2.42%
Volume:9.91K
Turnover:494.20K
Market Cap:219.11B
PE:14.56
High:51.25
Open:51.25
Low:48.50
Close:50.75
52wk High:93.83
52wk Low:40.25
Shares:4.42B
Float Shares:3.17B
Volume Ratio:0.01
T/O Rate:0.00%
Dividend:1.72
Dividend Rate:3.48%
EPS(TTM):3.40
EPS(LYR):3.15
ROE:60.70%
ROA:17.43%
PB:7.67
PE(LYR):15.73

Loading ...

Company Profile

Company Name:
Novo-Nordisk A/S
Exchange:
PINK LIMITED
Establishment Date:
1923
Employees:
69150
Office Location:
Novo Alle 1,Bagsvaerd,Capital Region of Denmark,Denmark
Zip Code:
2880
Fax:
- -
Introduction:
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.